SM

Sumayyath Mohammed Shafi

Active Director Managing Director DIN 10874851
DIN 10874851 First appointment Dec 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sumayyath Mohammed Shafi

Data last updated:

Sumayyath Mohammed Shafi is a Managing Director at Travmedix Private Limited (since 2024).

DIN 10874851
Primary Designation Managing Director
First Appointment 17 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Travmedix Private Limited U86900KA2024PTC195924
Managing Director17 Dec 20242024Active

Board colleagues of Sumayyath Mohammed Shafi

NameDINCompanyDesignation
Elvis Tony Lewis10874850Travmedix Private LimitedDirector
Ridwan08219771Travmedix Private LimitedDirector

Directorship timeline

Open interactive timeline →
Travmedix Private Limited
Premium access

Shareholding and investment profile for Sumayyath Mohammed Shafi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumayyath Mohammed Shafi

Sumayyath Mohammed Shafi currently holds 1 directorship: Travmedix Private Limited (Managing Director, since 17 Dec 2024).

Sumayyath Mohammed Shafi was first appointed on 17 Dec 2024 as Managing Director at Travmedix Private Limited.

The current boards of Sumayyath Mohammed Shafi's companies include Elvis Tony Lewis (Travmedix Private Limited), Ridwan (Travmedix Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available